MarketCap
Facebook
X
Telegram
FMC Corporation Financial Ratios 2025-2006 | FMC
Brief overview of FMC Corporation's valuation multiples
Current figures are compared with the company's own five-year history for 2019–2023.
The current valuation set is P/E 5.02x (median 22.05x), EV/EBITDA 10.38x (median 11.83x), P/S 1.64x (median 2.8x). The combined multiple level is about 41.5% below the company's historical norm, suggesting more cautious expectations.
Current earnings relative to valuation equal about 19.9% on the 1/P/E measure. This is a valuation reference, not an expected payout.
End-period return metrics are ROE -83.1%, ROA -17.8%, ROCE -68.4%. Losses and negative capital returns make ordinary P/E-like references unstable or inapplicable.
The cash conversion cycle increased 692.6 days to 910.1 days, weakening working-capital efficiency.
Overall picture
FMC Corporation's discount may reflect genuine profitability issues rather than market inefficiency alone.
Annual Financial Ratios FMC Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -283.5 | 5.0 | 22.0 | 20.3 | 23.3 | 26.3 | 18.7 | 19.9 | 33.6 | 8.5 | 21.6 | 28.7 | 17.7 | 15.6 | 21.3 | 7.6 | - | - | - |
P/S |
1.6 | 3.8 | 1.5 | 2.8 | 3.0 | 2.8 | 2.7 | 2.0 | 3.7 | 2.1 | 1.3 | 1.6 | 2.2 | 2.0 | 1.7 | 1.2 | 0.6 | - | - | - |
EPS |
-13.7 | -0.1 | 10.6 | 5.8 | 5.8 | 4.3 | 3.6 | 3.7 | 4.0 | 1.6 | 3.7 | 2.3 | 2.2 | 3.0 | 2.6 | 1.2 | 3.1 | 4.1 | 1.7 | - |
EV (Enterprise Value) |
1.19 B | 4.26 B | 6.33 B | 15.7 B | 14.5 B | 12.3 B | 19.5 B | 16 B | 16.9 B | 11.1 B | 8.48 B | 10.3 B | 12 B | 10.1 B | 8 B | 3.51 B | 1.65 B | -76.6 M | -75.5 M | -166 M |
EBITDA per Share |
-9.93 | 3.29 | 5.92 | 10.4 | 9.39 | 8.17 | 7.91 | 8.11 | 3.26 | 4.7 | 2.15 | 5.35 | 6.12 | 6.02 | 5.26 | 3.61 | 6.4 | - | - | - |
EV/EBITDA |
-1.0 | 10.4 | 8.6 | 11.9 | 11.8 | 14.3 | 15.0 | 10.9 | 31.0 | 14.1 | 21.5 | 10.8 | 11.5 | 9.9 | 8.6 | 6.7 | 3.6 | -0.1 | -0.2 | - |
PEG |
0.01 | 24.31 | -1.52 | 0.63 | 0.76 | 0.49 | -12.24 | -2.77 | 0.13 | -0.59 | 0.14 | 3.72 | -1.03 | 1.02 | 0.14 | - | - | - | - | - |
P/B |
0.2 | 0.4 | 0.6 | 1.5 | 1.4 | 1.3 | 4.9 | 2.9 | 3.9 | 3.5 | 2.2 | 4.3 | 5.4 | 4.7 | 4.4 | 1.1 | 0.6 | - | - | - |
P/CF |
- | - | - | - | - | - | 31.8 | 44.4 | 42.7 | 19.1 | -8.9 | 44.6 | 78.9 | 48.0 | 29.8 | - | - | - | - | - |
ROE % |
-83.07 | -0.36 | 29.96 | 21.66 | 23.53 | 17.91 | 18.64 | 15.64 | 19.79 | 10.49 | 25.62 | 19.66 | 18.69 | 26.77 | 28.06 | 15.25 | 21.23 | 33.74 | 11.79 | - |
ROA % |
-17.76 | -0.14 | 11.08 | 6.59 | 6.93 | 5.42 | 4.84 | 5.03 | 5.82 | 3.41 | 7.73 | 5.76 | 5.61 | 9.52 | 9.77 | 5.20 | 7.29 | 10.17 | - | - |
ROCE % |
-68.39 | 5.23 | 12.60 | 33.65 | 32.91 | 29.08 | 12.36 | 13.21 | 4.64 | 10.47 | 3.53 | 16.96 | 21.57 | 21.32 | 21.95 | 34.21 | 31.09 | 55.45 | 20.31 | - |
Current Ratio |
- | - | - | - | - | - | 1.5 | 1.3 | 1.7 | 2.0 | 2.0 | 1.5 | 1.5 | 1.9 | 2.0 | - | - | - | - | - |
DSO |
836.5 | 835.7 | 229.2 | 175.3 | 183.6 | 188.2 | 194.8 | 193.6 | 275.7 | 217.7 | 220.1 | 166.4 | 147.4 | 115.3 | 100.6 | 93.8 | 92.8 | 40.3 | - | - |
DIO |
202.3 | 205.6 | 232.0 | 166.6 | 165.6 | 148.6 | 146.9 | 151.7 | 203.8 | 123.3 | 132.7 | 87.3 | 99.1 | 102.5 | 77.7 | 61.7 | 68.7 | 32.6 | - | - |
DPO |
128.6 | 96.3 | 127.4 | 125.4 | 131.7 | 129.9 | 130.1 | 119.9 | 146.7 | 62.3 | 66.9 | 59.4 | 68.4 | 67.2 | 75.7 | 60.1 | 62.2 | 31.8 | - | - |
Operating Cycle |
1038.8 | 1041.3 | 461.2 | 341.9 | 349.2 | 336.8 | 341.8 | 345.3 | 479.5 | 341.0 | 352.8 | 253.6 | 246.6 | 217.8 | 178.3 | 155.5 | 161.5 | 72.8 | - | - |
Cash Conversion Cycle |
910.1 | 945.0 | 333.8 | 216.6 | 217.5 | 206.9 | 211.7 | 225.4 | 332.8 | 278.7 | 285.8 | 194.2 | 178.2 | 150.6 | 102.6 | 95.5 | 99.2 | 41.0 | - | - |
All numbers in USD currency
Quarterly Financial Ratios FMC Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.25 | -4.52 | 0.53 | -0.12 | 0.52 | 2.35 | -0.02 | -0.03 | 0.24 | 1.56 | - | 0.96 | 1.06 | 1.65 | 1.52 | 1.24 | 1.57 | 1.41 | 0.38 | 0.86 | 1.42 | 1.59 | -0.02 | 0.69 | 1.32 | 1.63 | 0.24 | 0.54 | 0.96 | 1.98 | 3.94 | 0.41 | 0.56 | -0.93 | 0.12 | 0.59 | 0.49 | 0.36 | -1.53 | -0.02 | 5.54 | -0.35 | 0.57 | 0.42 | 0.82 | 0.49 | 0.2 | 0.13 | 0.86 | 0.95 | 0.74 | 0.65 | 0.76 | 0.86 | 0.55 | 0.61 | 0.75 | 0.65 | 1.14 | 0.9 | 1.06 | 0.39 | 0.95 |
EBITDA per Share |
-0.31 | -2.12 | 1.71 | 0.81 | 1.22 | 0.63 | 0.96 | 0.94 | 1.19 | 2.79 | - | 1.79 | 1.99 | 2.74 | 2.2 | 2.68 | 2.36 | 2.34 | 1.13 | 2.44 | 2.68 | 2.55 | 0.86 | 2.08 | 2.61 | 2.42 | 1.33 | 1.09 | 1.31 | 2.67 | 0.26 | 0.46 | 0.49 | 0.5 | 0.21 | 1.08 | 0.99 | 0.65 | -412 | 693 | 1.16 K | -549 | 0.41 | 1.06 | 1.47 | 1.25 | 1.35 | 1.57 | 1.64 | 1.63 | 1.03 | 1.68 | 1.73 | 1.55 | 1 | 1.62 | 1.52 | 1.3 | - | - | - | - | - |
ROE % |
-29.36 | -12.51 | 9.02 | 7.44 | 7.68 | 7.18 | 6.34 | 10.18 | 14.46 | 20.22 | 14.61 | 20.79 | 22.08 | 24.25 | 23.50 | 18.99 | 17.69 | 17.57 | 18.62 | 16.82 | 16.63 | 17.30 | 18.85 | 20.02 | 18.78 | 16.04 | 16.09 | 34.82 | 34.54 | 33.17 | 19.98 | 1.02 | 3.04 | 3.58 | 10.68 | -1.07 | -5.27 | 31.19 | 26.21 | 42.15 | 45.96 | 13.30 | 20.09 | 16.88 | 14.38 | 15.01 | 19.34 | 24.46 | 29.36 | 28.68 | 28.12 | 27.49 | 28.41 | 29.96 | 29.49 | 29.58 | 28.27 | 26.47 | 21.51 | 5.69 | 6.84 | 2.62 | - |
ROA % |
-7.29 | -3.77 | 3.38 | 2.81 | 2.91 | 2.63 | 1.87 | 3.02 | 4.99 | 6.54 | 4.87 | 6.41 | 5.28 | 7.16 | 6.99 | 5.67 | 5.23 | 5.17 | 5.41 | 4.90 | 4.72 | 4.68 | 4.84 | 5.19 | 5.01 | 4.54 | 5.03 | 10.47 | 10.34 | 9.85 | 5.82 | 0.32 | 1.02 | 1.27 | 3.41 | -0.08 | -1.42 | 9.26 | 7.73 | 12.39 | 13.49 | 3.79 | 5.76 | 4.84 | 4.13 | 4.34 | 5.61 | 7.43 | 9.15 | 9.29 | 9.52 | 9.26 | 9.52 | 9.99 | 9.77 | 10.13 | 9.85 | 9.38 | 7.79 | 2.04 | 2.39 | 0.92 | - |
ROCE % |
-10.74 | -3.36 | 8.51 | 7.34 | 9.05 | 10.02 | 17.38 | 22.24 | 26.53 | 32.17 | 23.46 | 32.37 | 32.64 | 34.24 | 33.01 | 29.06 | 28.83 | 28.95 | 30.46 | 29.93 | 29.63 | 31.16 | 32.44 | 33.71 | 30.76 | 24.45 | 23.74 | 19.33 | 17.35 | 14.70 | 5.91 | 6.08 | 8.28 | 10.87 | 12.42 | 8.01 | 4.46 | 5.64 | -2.69 | 3.80 | 8.36 | 12.61 | 27.10 | 35.38 | 38.59 | 39.91 | 43.36 | 41.08 | 43.13 | 43.67 | 43.17 | 45.02 | 46.10 | 47.14 | 47.34 | 45.73 | 46.17 | 45.63 | 39.50 | 11.38 | 12.00 | 6.36 | - |
DSO |
275.1 | 454.9 | 259.6 | 333.8 | 239.5 | 242.6 | 267.5 | 248.5 | 269.2 | 206.1 | - | 86.1 | 90.1 | 184.2 | 164.2 | 196.1 | 189.6 | 189.5 | 188.7 | 196.1 | 194.2 | 180.3 | 169.6 | 205.3 | 182.4 | 175.4 | 184.9 | 220.2 | 176.1 | 175.3 | 194.6 | 303.6 | 298.7 | 294.2 | 224.3 | 245.6 | 251.0 | 266.6 | 187.9 | 203.4 | 190.4 | 239.0 | 164.7 | 178.5 | 184.0 | 186.1 | 119.8 | 141.5 | 154.6 | 128.2 | 107.0 | 122.0 | 113.4 | 99.7 | 93.5 | 98.6 | 104.6 | 100.2 | 97.1 | 101.2 | 97.0 | 90.6 | - |
DIO |
233.3 | 306.0 | 196.2 | 265.9 | 190.0 | 215.3 | 282.9 | 309.2 | 312.4 | 213.0 | - | 87.8 | 84.3 | 182.5 | - | 190.4 | 170.4 | 157.0 | - | 161.7 | 158.0 | 140.0 | - | 159.5 | 141.6 | 143.9 | - | 177.1 | 140.9 | 148.3 | - | 238.1 | 214.4 | 176.8 | - | 105.5 | 115.0 | 149.5 | - | 119.6 | 125.6 | 157.2 | - | 103.5 | 115.8 | 127.5 | - | 96.2 | 114.5 | 109.0 | - | 114.8 | 108.7 | 88.1 | - | 74.7 | 83.6 | 75.3 | 62.8 | 61.6 | 67.7 | 69.0 | - |
DPO |
121.9 | 181.0 | 121.0 | 154.2 | 100.8 | 91.7 | 98.8 | 128.8 | 173.8 | 145.6 | - | 53.0 | 56.0 | 128.6 | - | 151.0 | 143.4 | 135.0 | - | 139.7 | 136.6 | 122.4 | - | 141.2 | 125.3 | 119.5 | - | 137.4 | 109.3 | 109.3 | - | 171.4 | 154.3 | 123.9 | - | 69.9 | 76.2 | 84.3 | - | 60.3 | 63.4 | 87.3 | - | 64.5 | 72.1 | 83.9 | - | 66.4 | 79.1 | 72.0 | - | 73.8 | 71.3 | 63.5 | - | 72.8 | 81.5 | 70.3 | 53.9 | 50.0 | 49.9 | 23.5 | - |
Operating Cycle |
- | - | 455.8 | 599.7 | 429.5 | 457.9 | 550.4 | 557.7 | 581.6 | 419.2 | - | 173.9 | 174.4 | 366.7 | 164.2 | 386.5 | 360.0 | 346.5 | 188.7 | 357.8 | 352.2 | 320.3 | 169.6 | 364.8 | 323.9 | 319.3 | 184.9 | 397.2 | 317.1 | 323.6 | 194.6 | 541.8 | 513.1 | 470.9 | 224.3 | 351.1 | 366.0 | 416.1 | 187.9 | 323.0 | 316.1 | 396.1 | 164.7 | 282.0 | 299.8 | 313.5 | 119.8 | 237.7 | 269.1 | 237.1 | 107.0 | 236.8 | 222.0 | 187.8 | 93.5 | 173.2 | 188.2 | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 334.8 | 445.5 | 328.7 | 366.2 | 451.6 | 428.9 | 407.8 | 273.6 | - | 120.9 | 118.4 | 238.1 | 164.2 | 235.4 | 216.6 | 211.5 | 188.7 | 218.0 | 215.6 | 197.9 | 169.6 | 223.6 | 198.7 | 199.8 | 184.9 | 259.9 | 207.8 | 214.3 | 194.6 | 370.4 | 358.9 | 347.0 | 224.3 | 281.2 | 289.8 | 331.9 | 187.9 | 262.6 | 252.7 | 308.9 | 164.7 | 217.6 | 227.7 | 229.6 | 119.8 | 171.3 | 190.1 | 165.1 | 107.0 | 163.0 | 150.8 | 124.4 | 93.5 | 100.5 | 106.8 | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company FMC Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Agricultural inputs industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
The Mosaic Company
MOS
|
$ 22.3 | 0.09 % | $ 7.08 B |  USA |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M |  China |
 |
The Scotts Miracle-Gro Company
SMG
|
$ 69.31 | 2.64 % | $ 3.99 B | USA |
 |
CVR Partners, LP
UAN
|
$ 123.06 | -0.66 % | $ 1.3 B | USA |
 |
American Vanguard Corporation
AVD
|
$ 2.57 | 1.58 % | $ 73.1 M | USA |
 |
CF Industries Holdings
CF
|
$ 125.07 | -1.29 % | $ 20.3 B | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.34 | -1.44 % | $ 21.5 M |  Argentina |
 |
Corteva
CTVA
|
$ 89.25 | 0.53 % | $ 60.7 B | USA |
 |
Origin Agritech Limited
SEED
|
$ 1.01 | 1.0 % | $ 7.57 M | China |
 |
ICL Group Ltd
ICL
|
$ 5.28 | -0.38 % | $ 6.81 B |  Israel |
 |
Arcadia Biosciences
RKDA
|
$ 0.64 | 2.89 % | $ 876 K | USA |
 |
Intrepid Potash
IPI
|
$ 34.22 | -0.67 % | $ 445 M | USA |
 |
Nutrien Ltd.
NTR
|
$ 68.1 | -0.64 % | $ 33.1 B |  Canada |